nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketamine—ABCB1—ovarian cancer	0.397	1	CbGaD
Ketamine—ABCB1—Topotecan—ovarian cancer	0.0569	0.159	CbGbCtD
Ketamine—CYP2C8—Paclitaxel—ovarian cancer	0.0416	0.116	CbGbCtD
Ketamine—ABCB1—Vinorelbine—ovarian cancer	0.0401	0.112	CbGbCtD
Ketamine—CYP3A4—Topotecan—ovarian cancer	0.0341	0.0954	CbGbCtD
Ketamine—CYP2B6—Doxorubicin—ovarian cancer	0.0296	0.0829	CbGbCtD
Ketamine—CYP2C9—Paclitaxel—ovarian cancer	0.029	0.0812	CbGbCtD
Ketamine—ABCB1—Paclitaxel—ovarian cancer	0.0282	0.0788	CbGbCtD
Ketamine—CYP3A4—Vinorelbine—ovarian cancer	0.024	0.0672	CbGbCtD
Ketamine—ABCB1—Docetaxel—ovarian cancer	0.0204	0.057	CbGbCtD
Ketamine—CYP3A4—Paclitaxel—ovarian cancer	0.0169	0.0472	CbGbCtD
Ketamine—ABCB1—Doxorubicin—ovarian cancer	0.0152	0.0425	CbGbCtD
Ketamine—CYP3A4—Docetaxel—ovarian cancer	0.0122	0.0342	CbGbCtD
Ketamine—CYP3A4—Doxorubicin—ovarian cancer	0.0091	0.0255	CbGbCtD
Ketamine—GRIN3B—testis—ovarian cancer	0.00438	0.1	CbGeAlD
Ketamine—Convulsion—Altretamine—ovarian cancer	0.00311	0.0344	CcSEcCtD
Ketamine—Muscle twitching—Chlorambucil—ovarian cancer	0.00297	0.0329	CcSEcCtD
Ketamine—PTGS1—oviduct—ovarian cancer	0.00287	0.0656	CbGeAlD
Ketamine—Cystitis noninfective—Chlorambucil—ovarian cancer	0.00285	0.0316	CcSEcCtD
Ketamine—Cystitis—Chlorambucil—ovarian cancer	0.00282	0.0312	CcSEcCtD
Ketamine—Anorexia—Altretamine—ovarian cancer	0.00279	0.0309	CcSEcCtD
Ketamine—Bladder pain—Chlorambucil—ovarian cancer	0.00264	0.0292	CcSEcCtD
Ketamine—Decreased appetite—Altretamine—ovarian cancer	0.00254	0.0282	CcSEcCtD
Ketamine—Cystitis noninfective—Melphalan—ovarian cancer	0.00248	0.0275	CcSEcCtD
Ketamine—Cystitis—Melphalan—ovarian cancer	0.00245	0.0272	CcSEcCtD
Ketamine—Bladder pain—Melphalan—ovarian cancer	0.0023	0.0255	CcSEcCtD
Ketamine—GRIN2C—testis—ovarian cancer	0.00211	0.0482	CbGeAlD
Ketamine—TACR1—female reproductive system—ovarian cancer	0.00198	0.0453	CbGeAlD
Ketamine—GRIN2D—testis—ovarian cancer	0.00196	0.0448	CbGeAlD
Ketamine—Vomiting—Altretamine—ovarian cancer	0.00186	0.0206	CcSEcCtD
Ketamine—GRIN3A—testis—ovarian cancer	0.00184	0.0422	CbGeAlD
Ketamine—Nausea—Altretamine—ovarian cancer	0.00174	0.0193	CcSEcCtD
Ketamine—Pain—Carboplatin—ovarian cancer	0.00173	0.0192	CcSEcCtD
Ketamine—GRIN2A—vagina—ovarian cancer	0.00163	0.0373	CbGeAlD
Ketamine—TACR1—testis—ovarian cancer	0.0016	0.0366	CbGeAlD
Ketamine—OPRK1—female reproductive system—ovarian cancer	0.00154	0.0353	CbGeAlD
Ketamine—GRIN2A—testis—ovarian cancer	0.00145	0.0333	CbGeAlD
Ketamine—Nystagmus—Epirubicin—ovarian cancer	0.0012	0.0132	CcSEcCtD
Ketamine—TACR1—lymph node—ovarian cancer	0.00116	0.0265	CbGeAlD
Ketamine—Arrhythmia—Melphalan—ovarian cancer	0.00114	0.0126	CcSEcCtD
Ketamine—Nystagmus—Doxorubicin—ovarian cancer	0.00111	0.0123	CcSEcCtD
Ketamine—Convulsion—Chlorambucil—ovarian cancer	0.0011	0.0122	CcSEcCtD
Ketamine—SLC6A2—decidua—ovarian cancer	0.00102	0.0234	CbGeAlD
Ketamine—Arrhythmia—Vinorelbine—ovarian cancer	0.000996	0.011	CcSEcCtD
Ketamine—Anorexia—Chlorambucil—ovarian cancer	0.000992	0.011	CcSEcCtD
Ketamine—Erythema—Vinorelbine—ovarian cancer	0.000971	0.0108	CcSEcCtD
Ketamine—Convulsion—Melphalan—ovarian cancer	0.000963	0.0107	CcSEcCtD
Ketamine—Anaphylactic shock—Topotecan—ovarian cancer	0.000926	0.0103	CcSEcCtD
Ketamine—Anaphylactic shock—Melphalan—ovarian cancer	0.000907	0.01	CcSEcCtD
Ketamine—Decreased appetite—Chlorambucil—ovarian cancer	0.000904	0.01	CcSEcCtD
Ketamine—SLC6A2—gonad—ovarian cancer	0.000898	0.0206	CbGeAlD
Ketamine—Pain—Chlorambucil—ovarian cancer	0.00089	0.00986	CcSEcCtD
Ketamine—OPRM1—testis—ovarian cancer	0.000884	0.0203	CbGeAlD
Ketamine—Anorexia—Topotecan—ovarian cancer	0.000883	0.00978	CcSEcCtD
Ketamine—Anorexia—Melphalan—ovarian cancer	0.000865	0.00958	CcSEcCtD
Ketamine—Hypotension—Melphalan—ovarian cancer	0.000847	0.00939	CcSEcCtD
Ketamine—Cystitis noninfective—Epirubicin—ovarian cancer	0.000834	0.00924	CcSEcCtD
Ketamine—Salivary hypersecretion—Epirubicin—ovarian cancer	0.000829	0.00919	CcSEcCtD
Ketamine—Cystitis—Epirubicin—ovarian cancer	0.000825	0.00914	CcSEcCtD
Ketamine—Decreased appetite—Topotecan—ovarian cancer	0.000805	0.00892	CcSEcCtD
Ketamine—SLC6A2—female reproductive system—ovarian cancer	0.000802	0.0184	CbGeAlD
Ketamine—CYP2C8—endometrium—ovarian cancer	0.000796	0.0182	CbGeAlD
Ketamine—Anaphylactic shock—Vinorelbine—ovarian cancer	0.000792	0.00878	CcSEcCtD
Ketamine—Pain—Topotecan—ovarian cancer	0.000792	0.00878	CcSEcCtD
Ketamine—Decreased appetite—Melphalan—ovarian cancer	0.000788	0.00874	CcSEcCtD
Ketamine—Pain—Melphalan—ovarian cancer	0.000776	0.00859	CcSEcCtD
Ketamine—Bladder pain—Epirubicin—ovarian cancer	0.000772	0.00856	CcSEcCtD
Ketamine—Cystitis noninfective—Doxorubicin—ovarian cancer	0.000772	0.00855	CcSEcCtD
Ketamine—Salivary hypersecretion—Doxorubicin—ovarian cancer	0.000767	0.0085	CcSEcCtD
Ketamine—Bradycardia—Paclitaxel—ovarian cancer	0.000764	0.00846	CcSEcCtD
Ketamine—Cystitis—Doxorubicin—ovarian cancer	0.000763	0.00846	CcSEcCtD
Ketamine—Anorexia—Vinorelbine—ovarian cancer	0.000755	0.00837	CcSEcCtD
Ketamine—Hypotension—Vinorelbine—ovarian cancer	0.00074	0.0082	CcSEcCtD
Ketamine—PTGS1—epithelium—ovarian cancer	0.00072	0.0165	CbGeAlD
Ketamine—Bladder pain—Doxorubicin—ovarian cancer	0.000714	0.00792	CcSEcCtD
Ketamine—PTGS1—uterine cervix—ovarian cancer	0.000713	0.0163	CbGeAlD
Ketamine—Decreased appetite—Vinorelbine—ovarian cancer	0.000689	0.00763	CcSEcCtD
Ketamine—Pain—Vinorelbine—ovarian cancer	0.000678	0.00751	CcSEcCtD
Ketamine—Arrhythmia—Paclitaxel—ovarian cancer	0.00067	0.00743	CcSEcCtD
Ketamine—CYP2B6—gonad—ovarian cancer	0.000662	0.0152	CbGeAlD
Ketamine—Vomiting—Chlorambucil—ovarian cancer	0.000662	0.00733	CcSEcCtD
Ketamine—CYP2C8—female reproductive system—ovarian cancer	0.000659	0.0151	CbGeAlD
Ketamine—Erythema—Paclitaxel—ovarian cancer	0.000653	0.00724	CcSEcCtD
Ketamine—SLC6A2—testis—ovarian cancer	0.000648	0.0148	CbGeAlD
Ketamine—PTGS1—endometrium—ovarian cancer	0.000645	0.0148	CbGeAlD
Ketamine—Diplopia—Epirubicin—ovarian cancer	0.00062	0.00687	CcSEcCtD
Ketamine—Nausea—Chlorambucil—ovarian cancer	0.000618	0.00685	CcSEcCtD
Ketamine—Vision blurred—Paclitaxel—ovarian cancer	0.000615	0.00682	CcSEcCtD
Ketamine—CYP2C8—vagina—ovarian cancer	0.000596	0.0137	CbGeAlD
Ketamine—PTGS1—uterus—ovarian cancer	0.000595	0.0136	CbGeAlD
Ketamine—CYP2B6—female reproductive system—ovarian cancer	0.000591	0.0135	CbGeAlD
Ketamine—DRD2—testis—ovarian cancer	0.00059	0.0135	CbGeAlD
Ketamine—Vomiting—Topotecan—ovarian cancer	0.000589	0.00653	CcSEcCtD
Ketamine—CYP2C9—female reproductive system—ovarian cancer	0.000586	0.0134	CbGeAlD
Ketamine—Rash—Topotecan—ovarian cancer	0.000584	0.00647	CcSEcCtD
Ketamine—Dermatitis—Topotecan—ovarian cancer	0.000583	0.00647	CcSEcCtD
Ketamine—Vomiting—Melphalan—ovarian cancer	0.000577	0.00639	CcSEcCtD
Ketamine—Diplopia—Doxorubicin—ovarian cancer	0.000574	0.00636	CcSEcCtD
Ketamine—Rash—Melphalan—ovarian cancer	0.000572	0.00634	CcSEcCtD
Ketamine—Dermatitis—Melphalan—ovarian cancer	0.000571	0.00633	CcSEcCtD
Ketamine—Arrhythmia—Docetaxel—ovarian cancer	0.000568	0.00629	CcSEcCtD
Ketamine—Convulsion—Paclitaxel—ovarian cancer	0.000566	0.00627	CcSEcCtD
Ketamine—Erythema—Docetaxel—ovarian cancer	0.000553	0.00613	CcSEcCtD
Ketamine—Nausea—Topotecan—ovarian cancer	0.00055	0.0061	CcSEcCtD
Ketamine—ABCB1—myometrium—ovarian cancer	0.000542	0.0124	CbGeAlD
Ketamine—Nausea—Melphalan—ovarian cancer	0.000539	0.00597	CcSEcCtD
Ketamine—CYP2B6—vagina—ovarian cancer	0.000535	0.0122	CbGeAlD
Ketamine—PTGS1—female reproductive system—ovarian cancer	0.000535	0.0122	CbGeAlD
Ketamine—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000533	0.00591	CcSEcCtD
Ketamine—CYP2C8—testis—ovarian cancer	0.000532	0.0122	CbGeAlD
Ketamine—Shock—Paclitaxel—ovarian cancer	0.000524	0.00581	CcSEcCtD
Ketamine—ABCB1—embryo—ovarian cancer	0.000521	0.0119	CbGeAlD
Ketamine—Anorexia—Paclitaxel—ovarian cancer	0.000508	0.00563	CcSEcCtD
Ketamine—Vomiting—Vinorelbine—ovarian cancer	0.000504	0.00558	CcSEcCtD
Ketamine—Rash—Vinorelbine—ovarian cancer	0.0005	0.00554	CcSEcCtD
Ketamine—Dermatitis—Vinorelbine—ovarian cancer	0.000499	0.00553	CcSEcCtD
Ketamine—Hypotension—Paclitaxel—ovarian cancer	0.000498	0.00552	CcSEcCtD
Ketamine—PTGS1—female gonad—ovarian cancer	0.000486	0.0111	CbGeAlD
Ketamine—PTGS1—vagina—ovarian cancer	0.000483	0.0111	CbGeAlD
Ketamine—Convulsion—Docetaxel—ovarian cancer	0.00048	0.00531	CcSEcCtD
Ketamine—CYP2B6—testis—ovarian cancer	0.000477	0.0109	CbGeAlD
Ketamine—Nausea—Vinorelbine—ovarian cancer	0.000471	0.00522	CcSEcCtD
Ketamine—SLC6A2—lymph node—ovarian cancer	0.000469	0.0108	CbGeAlD
Ketamine—Decreased appetite—Paclitaxel—ovarian cancer	0.000463	0.00513	CcSEcCtD
Ketamine—Pain—Paclitaxel—ovarian cancer	0.000456	0.00505	CcSEcCtD
Ketamine—Anaphylactic shock—Docetaxel—ovarian cancer	0.000452	0.00501	CcSEcCtD
Ketamine—CYP3A4—female reproductive system—ovarian cancer	0.000446	0.0102	CbGeAlD
Ketamine—Shock—Docetaxel—ovarian cancer	0.000444	0.00492	CcSEcCtD
Ketamine—Bradycardia—Epirubicin—ovarian cancer	0.000437	0.00484	CcSEcCtD
Ketamine—PTGS1—testis—ovarian cancer	0.000431	0.00988	CbGeAlD
Ketamine—Anorexia—Docetaxel—ovarian cancer	0.000431	0.00477	CcSEcCtD
Ketamine—ABCB1—epithelium—ovarian cancer	0.000425	0.00975	CbGeAlD
Ketamine—Hypotension—Docetaxel—ovarian cancer	0.000422	0.00468	CcSEcCtD
Ketamine—ABCB1—uterine cervix—ovarian cancer	0.000422	0.00966	CbGeAlD
Ketamine—Bradycardia—Doxorubicin—ovarian cancer	0.000404	0.00448	CcSEcCtD
Ketamine—ABCB1—decidua—ovarian cancer	0.000402	0.00921	CbGeAlD
Ketamine—Decreased appetite—Docetaxel—ovarian cancer	0.000393	0.00435	CcSEcCtD
Ketamine—Pain—Docetaxel—ovarian cancer	0.000386	0.00428	CcSEcCtD
Ketamine—Arrhythmia—Epirubicin—ovarian cancer	0.000383	0.00425	CcSEcCtD
Ketamine—ABCB1—endometrium—ovarian cancer	0.000382	0.00874	CbGeAlD
Ketamine—Erythema—Epirubicin—ovarian cancer	0.000373	0.00414	CcSEcCtD
Ketamine—Arrhythmia—Doxorubicin—ovarian cancer	0.000354	0.00393	CcSEcCtD
Ketamine—ABCB1—gonad—ovarian cancer	0.000354	0.00811	CbGeAlD
Ketamine—Vision blurred—Epirubicin—ovarian cancer	0.000352	0.0039	CcSEcCtD
Ketamine—ABCB1—uterus—ovarian cancer	0.000352	0.00805	CbGeAlD
Ketamine—Erythema—Doxorubicin—ovarian cancer	0.000345	0.00383	CcSEcCtD
Ketamine—Vomiting—Paclitaxel—ovarian cancer	0.000339	0.00375	CcSEcCtD
Ketamine—Rash—Paclitaxel—ovarian cancer	0.000336	0.00372	CcSEcCtD
Ketamine—Dermatitis—Paclitaxel—ovarian cancer	0.000336	0.00372	CcSEcCtD
Ketamine—Vision blurred—Doxorubicin—ovarian cancer	0.000326	0.00361	CcSEcCtD
Ketamine—Convulsion—Epirubicin—ovarian cancer	0.000323	0.00358	CcSEcCtD
Ketamine—Nausea—Paclitaxel—ovarian cancer	0.000317	0.00351	CcSEcCtD
Ketamine—ABCB1—female reproductive system—ovarian cancer	0.000316	0.00724	CbGeAlD
Ketamine—PTGS1—lymph node—ovarian cancer	0.000313	0.00716	CbGeAlD
Ketamine—Anaphylactic shock—Epirubicin—ovarian cancer	0.000305	0.00338	CcSEcCtD
Ketamine—Shock—Epirubicin—ovarian cancer	0.0003	0.00332	CcSEcCtD
Ketamine—Convulsion—Doxorubicin—ovarian cancer	0.000299	0.00332	CcSEcCtD
Ketamine—ABCB1—bone marrow—ovarian cancer	0.000298	0.00683	CbGeAlD
Ketamine—Anorexia—Epirubicin—ovarian cancer	0.00029	0.00322	CcSEcCtD
Ketamine—ABCB1—female gonad—ovarian cancer	0.000288	0.00659	CbGeAlD
Ketamine—Vomiting—Docetaxel—ovarian cancer	0.000287	0.00318	CcSEcCtD
Ketamine—ABCB1—vagina—ovarian cancer	0.000286	0.00655	CbGeAlD
Ketamine—Rash—Docetaxel—ovarian cancer	0.000285	0.00316	CcSEcCtD
Ketamine—Hypotension—Epirubicin—ovarian cancer	0.000285	0.00315	CcSEcCtD
Ketamine—Dermatitis—Docetaxel—ovarian cancer	0.000285	0.00315	CcSEcCtD
Ketamine—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000282	0.00312	CcSEcCtD
Ketamine—Shock—Doxorubicin—ovarian cancer	0.000277	0.00307	CcSEcCtD
Ketamine—Anorexia—Doxorubicin—ovarian cancer	0.000269	0.00298	CcSEcCtD
Ketamine—Nausea—Docetaxel—ovarian cancer	0.000268	0.00297	CcSEcCtD
Ketamine—Decreased appetite—Epirubicin—ovarian cancer	0.000265	0.00294	CcSEcCtD
Ketamine—Hypotension—Doxorubicin—ovarian cancer	0.000263	0.00292	CcSEcCtD
Ketamine—Pain—Epirubicin—ovarian cancer	0.000261	0.00289	CcSEcCtD
Ketamine—ABCB1—testis—ovarian cancer	0.000255	0.00584	CbGeAlD
Ketamine—Decreased appetite—Doxorubicin—ovarian cancer	0.000245	0.00272	CcSEcCtD
Ketamine—Pain—Doxorubicin—ovarian cancer	0.000241	0.00267	CcSEcCtD
Ketamine—Vomiting—Epirubicin—ovarian cancer	0.000194	0.00215	CcSEcCtD
Ketamine—Rash—Epirubicin—ovarian cancer	0.000192	0.00213	CcSEcCtD
Ketamine—Dermatitis—Epirubicin—ovarian cancer	0.000192	0.00213	CcSEcCtD
Ketamine—ABCB1—lymph node—ovarian cancer	0.000185	0.00423	CbGeAlD
Ketamine—Nausea—Epirubicin—ovarian cancer	0.000181	0.00201	CcSEcCtD
Ketamine—Vomiting—Doxorubicin—ovarian cancer	0.000179	0.00199	CcSEcCtD
Ketamine—Rash—Doxorubicin—ovarian cancer	0.000178	0.00197	CcSEcCtD
Ketamine—Dermatitis—Doxorubicin—ovarian cancer	0.000178	0.00197	CcSEcCtD
Ketamine—Nausea—Doxorubicin—ovarian cancer	0.000167	0.00186	CcSEcCtD
Ketamine—OPRD1—Signaling Pathways—PIK3CD—ovarian cancer	1.89e-05	0.00017	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CG—ovarian cancer	1.89e-05	0.000169	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—APC—ovarian cancer	1.89e-05	0.000169	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—NRAS—ovarian cancer	1.89e-05	0.000169	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.88e-05	0.000168	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—PIK3CA—ovarian cancer	1.87e-05	0.000168	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.87e-05	0.000168	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.86e-05	0.000167	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.86e-05	0.000167	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—KRAS—ovarian cancer	1.85e-05	0.000166	CbGpPWpGaD
Ketamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	1.84e-05	0.000165	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	1.81e-05	0.000163	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MAPK3—ovarian cancer	1.81e-05	0.000162	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PPP2R1A—ovarian cancer	1.8e-05	0.000162	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.8e-05	0.000162	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CD—ovarian cancer	1.8e-05	0.000161	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—PIK3CA—ovarian cancer	1.78e-05	0.00016	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.77e-05	0.000158	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CAV1—ovarian cancer	1.75e-05	0.000157	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—CAV1—ovarian cancer	1.74e-05	0.000157	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.73e-05	0.000155	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—TP53—ovarian cancer	1.73e-05	0.000155	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CB—ovarian cancer	1.73e-05	0.000155	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—MAPK1—ovarian cancer	1.72e-05	0.000154	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—EGFR—ovarian cancer	1.72e-05	0.000154	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—PIK3CA—ovarian cancer	1.7e-05	0.000153	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ESR1—ovarian cancer	1.69e-05	0.000151	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—ABCB1—ovarian cancer	1.68e-05	0.000151	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—ERBB2—ovarian cancer	1.67e-05	0.00015	CbGpPWpGaD
Ketamine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.67e-05	0.00015	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6ST—ovarian cancer	1.66e-05	0.000149	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—CXCL8—ovarian cancer	1.66e-05	0.000149	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CD—ovarian cancer	1.66e-05	0.000149	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—FASN—ovarian cancer	1.65e-05	0.000148	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—TYMS—ovarian cancer	1.65e-05	0.000148	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—HRAS—ovarian cancer	1.65e-05	0.000148	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.65e-05	0.000148	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MTOR—ovarian cancer	1.65e-05	0.000148	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CB—ovarian cancer	1.65e-05	0.000148	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—PIK3CA—ovarian cancer	1.64e-05	0.000147	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC5A5—ovarian cancer	1.63e-05	0.000146	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—KRAS—ovarian cancer	1.62e-05	0.000146	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CG—ovarian cancer	1.59e-05	0.000143	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—APC—ovarian cancer	1.59e-05	0.000143	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—NRAS—ovarian cancer	1.59e-05	0.000143	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.59e-05	0.000143	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—IL2—ovarian cancer	1.58e-05	0.000142	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CXCL8—ovarian cancer	1.58e-05	0.000142	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—IL6—ovarian cancer	1.58e-05	0.000142	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—HRAS—ovarian cancer	1.57e-05	0.000141	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—SLC2A1—ovarian cancer	1.57e-05	0.000141	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CB—ovarian cancer	1.57e-05	0.000141	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CDKN1B—ovarian cancer	1.55e-05	0.000139	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—FASN—ovarian cancer	1.55e-05	0.000139	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.53e-05	0.000138	CbGpPWpGaD
Ketamine—OPRD1—GPCR downstream signaling—AKT1—ovarian cancer	1.53e-05	0.000137	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK3—ovarian cancer	1.53e-05	0.000137	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.53e-05	0.000137	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.52e-05	0.000136	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CASP3—ovarian cancer	1.52e-05	0.000136	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL2—ovarian cancer	1.51e-05	0.000136	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CYP1B1—ovarian cancer	1.51e-05	0.000135	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—IL6—ovarian cancer	1.51e-05	0.000135	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—CXCL8—ovarian cancer	1.51e-05	0.000135	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—PIK3CA—ovarian cancer	1.49e-05	0.000134	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CCND1—ovarian cancer	1.48e-05	0.000132	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.47e-05	0.000132	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—ERBB2—ovarian cancer	1.46e-05	0.000131	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—CTNNB1—ovarian cancer	1.46e-05	0.000131	CbGpPWpGaD
Ketamine—TACR1—Signaling Pathways—AKT1—ovarian cancer	1.46e-05	0.000131	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—MAPK1—ovarian cancer	1.45e-05	0.00013	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—EGFR—ovarian cancer	1.45e-05	0.00013	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MTOR—ovarian cancer	1.45e-05	0.00013	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CB—ovarian cancer	1.45e-05	0.00013	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL2—ovarian cancer	1.44e-05	0.000129	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.44e-05	0.000129	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TERT—ovarian cancer	1.43e-05	0.000129	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MMP9—ovarian cancer	1.43e-05	0.000129	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PTEN—ovarian cancer	1.42e-05	0.000128	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.42e-05	0.000128	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.41e-05	0.000126	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CD—ovarian cancer	1.4e-05	0.000126	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—TYMS—ovarian cancer	1.4e-05	0.000126	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CD—ovarian cancer	1.4e-05	0.000125	CbGpPWpGaD
Ketamine—OPRD1—Signaling by GPCR—AKT1—ovarian cancer	1.39e-05	0.000125	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CXCL8—ovarian cancer	1.39e-05	0.000125	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—PIK3CA—ovarian cancer	1.39e-05	0.000125	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—HRAS—ovarian cancer	1.38e-05	0.000124	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—KRAS—ovarian cancer	1.37e-05	0.000123	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CDKN1B—ovarian cancer	1.36e-05	0.000122	CbGpPWpGaD
Ketamine—OPRK1—GPCR downstream signaling—AKT1—ovarian cancer	1.34e-05	0.00012	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PPP2R1A—ovarian cancer	1.34e-05	0.00012	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—CAV1—ovarian cancer	1.33e-05	0.000119	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CASP3—ovarian cancer	1.33e-05	0.000119	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL2—ovarian cancer	1.33e-05	0.000119	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CAV1—ovarian cancer	1.33e-05	0.000119	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—IL6—ovarian cancer	1.32e-05	0.000119	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CCND1—ovarian cancer	1.29e-05	0.000116	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—VEGFA—ovarian cancer	1.29e-05	0.000115	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—CTNNB1—ovarian cancer	1.28e-05	0.000115	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ESR1—ovarian cancer	1.28e-05	0.000115	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—STAT3—ovarian cancer	1.27e-05	0.000114	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—NRAS—ovarian cancer	1.27e-05	0.000114	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—PIK3CA—ovarian cancer	1.26e-05	0.000113	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6ST—ovarian cancer	1.26e-05	0.000113	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MMP9—ovarian cancer	1.26e-05	0.000113	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—YAP1—ovarian cancer	1.25e-05	0.000112	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PTEN—ovarian cancer	1.25e-05	0.000112	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.25e-05	0.000112	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.24e-05	0.000111	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—ERBB2—ovarian cancer	1.24e-05	0.000111	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CB—ovarian cancer	1.22e-05	0.00011	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MTOR—ovarian cancer	1.22e-05	0.00011	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—TYMS—ovarian cancer	1.22e-05	0.000109	CbGpPWpGaD
Ketamine—OPRK1—Signaling by GPCR—AKT1—ovarian cancer	1.22e-05	0.000109	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CB—ovarian cancer	1.22e-05	0.000109	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK3—ovarian cancer	1.22e-05	0.000109	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CG—ovarian cancer	1.21e-05	0.000109	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—APC—ovarian cancer	1.21e-05	0.000108	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CG—ovarian cancer	1.21e-05	0.000108	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—NRAS—ovarian cancer	1.21e-05	0.000108	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MYC—ovarian cancer	1.18e-05	0.000106	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CXCL8—ovarian cancer	1.17e-05	0.000105	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—HRAS—ovarian cancer	1.17e-05	0.000105	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—ABCB1—ovarian cancer	1.16e-05	0.000104	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—MAPK1—ovarian cancer	1.16e-05	0.000104	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—EGFR—ovarian cancer	1.16e-05	0.000104	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK3—ovarian cancer	1.16e-05	0.000104	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CDKN1B—ovarian cancer	1.15e-05	0.000103	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—TYMS—ovarian cancer	1.14e-05	0.000102	CbGpPWpGaD
Ketamine—OPRM1—GPCR downstream signaling—AKT1—ovarian cancer	1.13e-05	0.000102	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—VEGFA—ovarian cancer	1.13e-05	0.000101	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—CAV1—ovarian cancer	1.13e-05	0.000101	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CASP3—ovarian cancer	1.12e-05	0.000101	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL2—ovarian cancer	1.12e-05	0.000101	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—STAT3—ovarian cancer	1.12e-05	0.0001	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—IL6—ovarian cancer	1.12e-05	0.0001	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—NRAS—ovarian cancer	1.11e-05	0.0001	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—MAPK1—ovarian cancer	1.1e-05	9.88e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—EGFR—ovarian cancer	1.1e-05	9.88e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—KRAS—ovarian cancer	1.09e-05	9.81e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CCND1—ovarian cancer	1.09e-05	9.81e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—CTNNB1—ovarian cancer	1.08e-05	9.72e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.08e-05	9.66e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK3—ovarian cancer	1.07e-05	9.58e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.07e-05	9.57e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CD—ovarian cancer	1.06e-05	9.53e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MMP9—ovarian cancer	1.06e-05	9.53e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PTEN—ovarian cancer	1.06e-05	9.47e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PTEN—ovarian cancer	1.05e-05	9.44e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—PIK3CA—ovarian cancer	1.05e-05	9.44e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—KRAS—ovarian cancer	1.04e-05	9.33e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MYC—ovarian cancer	1.04e-05	9.31e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling by GPCR—AKT1—ovarian cancer	1.03e-05	9.24e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CG—ovarian cancer	1.03e-05	9.21e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—FASN—ovarian cancer	1.02e-05	9.15e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—MAPK1—ovarian cancer	1.02e-05	9.11e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—EGFR—ovarian cancer	1.02e-05	9.11e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—PIK3CA—ovarian cancer	1e-05	9.02e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC5A5—ovarian cancer	1e-05	9e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—CAV1—ovarian cancer	9.82e-06	8.81e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—TP53—ovarian cancer	9.72e-06	8.72e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—SLC2A1—ovarian cancer	9.68e-06	8.69e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—KRAS—ovarian cancer	9.59e-06	8.61e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—PIK3CA—ovarian cancer	9.55e-06	8.57e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—VEGFA—ovarian cancer	9.53e-06	8.56e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—STAT3—ovarian cancer	9.44e-06	8.47e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—NRAS—ovarian cancer	9.42e-06	8.45e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—ERBB2—ovarian cancer	9.38e-06	8.42e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—HRAS—ovarian cancer	9.3e-06	8.34e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CB—ovarian cancer	9.29e-06	8.34e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CYP1B1—ovarian cancer	9.28e-06	8.33e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CB—ovarian cancer	9.26e-06	8.31e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MTOR—ovarian cancer	9.26e-06	8.31e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—CAV1—ovarian cancer	9.17e-06	8.23e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CD—ovarian cancer	9.02e-06	8.1e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK3—ovarian cancer	9.02e-06	8.09e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CG—ovarian cancer	8.94e-06	8.03e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—IL6—ovarian cancer	8.9e-06	7.98e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CXCL8—ovarian cancer	8.9e-06	7.98e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—HRAS—ovarian cancer	8.84e-06	7.93e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—PIK3CA—ovarian cancer	8.81e-06	7.91e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MYC—ovarian cancer	8.77e-06	7.87e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.76e-06	7.86e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CDKN1B—ovarian cancer	8.69e-06	7.8e-05	CbGpPWpGaD
Ketamine—DRD2—GPCR downstream signaling—AKT1—ovarian cancer	8.59e-06	7.71e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—MAPK1—ovarian cancer	8.58e-06	7.7e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—EGFR—ovarian cancer	8.58e-06	7.7e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—TP53—ovarian cancer	8.52e-06	7.65e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CASP3—ovarian cancer	8.51e-06	7.64e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL2—ovarian cancer	8.5e-06	7.63e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—IL6—ovarian cancer	8.46e-06	7.59e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CG—ovarian cancer	8.35e-06	7.5e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CCND1—ovarian cancer	8.29e-06	7.44e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	8.23e-06	7.39e-05	CbGpPWpGaD
Ketamine—OPRD1—Signaling Pathways—AKT1—ovarian cancer	8.21e-06	7.37e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—CTNNB1—ovarian cancer	8.21e-06	7.36e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—HRAS—ovarian cancer	8.15e-06	7.31e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—KRAS—ovarian cancer	8.1e-06	7.27e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MMP9—ovarian cancer	8.05e-06	7.22e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PTEN—ovarian cancer	8.03e-06	7.2e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PTEN—ovarian cancer	8e-06	7.18e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CB—ovarian cancer	7.87e-06	7.06e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CD—ovarian cancer	7.86e-06	7.06e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling by GPCR—AKT1—ovarian cancer	7.8e-06	7e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—IL6—ovarian cancer	7.8e-06	7e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—ABCB1—ovarian cancer	7.64e-06	6.86e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—TYMS—ovarian cancer	7.51e-06	6.74e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—PIK3CA—ovarian cancer	7.45e-06	6.68e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—PIK3CA—ovarian cancer	7.42e-06	6.66e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CD—ovarian cancer	7.34e-06	6.59e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—VEGFA—ovarian cancer	7.22e-06	6.48e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—TP53—ovarian cancer	7.2e-06	6.46e-05	CbGpPWpGaD
Ketamine—OPRK1—Signaling Pathways—AKT1—ovarian cancer	7.2e-06	6.46e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—STAT3—ovarian cancer	7.15e-06	6.42e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—NRAS—ovarian cancer	7.14e-06	6.4e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—HRAS—ovarian cancer	6.89e-06	6.18e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CB—ovarian cancer	6.85e-06	6.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK3—ovarian cancer	6.83e-06	6.13e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PTEN—ovarian cancer	6.8e-06	6.1e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MYC—ovarian cancer	6.65e-06	5.97e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—IL6—ovarian cancer	6.59e-06	5.92e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—MAPK1—ovarian cancer	6.5e-06	5.84e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—EGFR—ovarian cancer	6.5e-06	5.83e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CB—ovarian cancer	6.4e-06	5.74e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—KRAS—ovarian cancer	6.14e-06	5.51e-05	CbGpPWpGaD
Ketamine—OPRM1—Signaling Pathways—AKT1—ovarian cancer	6.08e-06	5.46e-05	CbGpPWpGaD
Ketamine—PTGS1—Metabolism—AKT1—ovarian cancer	6.06e-06	5.44e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—CAV1—ovarian cancer	6.05e-06	5.43e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PTEN—ovarian cancer	5.92e-06	5.31e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—PIK3CA—ovarian cancer	5.66e-06	5.08e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—PIK3CA—ovarian cancer	5.64e-06	5.06e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PTEN—ovarian cancer	5.53e-06	4.96e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CG—ovarian cancer	5.51e-06	4.94e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—TP53—ovarian cancer	5.46e-06	4.9e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—HRAS—ovarian cancer	5.22e-06	4.69e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—IL6—ovarian cancer	5e-06	4.48e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CD—ovarian cancer	4.84e-06	4.35e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—PIK3CA—ovarian cancer	4.8e-06	4.3e-05	CbGpPWpGaD
Ketamine—CYP2B6—Metabolism—AKT1—ovarian cancer	4.63e-06	4.15e-05	CbGpPWpGaD
Ketamine—DRD2—Signaling Pathways—AKT1—ovarian cancer	4.61e-06	4.14e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CB—ovarian cancer	4.22e-06	3.79e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—PIK3CA—ovarian cancer	4.18e-06	3.75e-05	CbGpPWpGaD
Ketamine—CYP2C8—Metabolism—AKT1—ovarian cancer	3.92e-06	3.52e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—PIK3CA—ovarian cancer	3.9e-06	3.5e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PTEN—ovarian cancer	3.65e-06	3.27e-05	CbGpPWpGaD
Ketamine—ABCB1—Metabolism—AKT1—ovarian cancer	3.41e-06	3.06e-05	CbGpPWpGaD
Ketamine—CYP2C9—Metabolism—AKT1—ovarian cancer	3.19e-06	2.86e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.57e-06	2.31e-05	CbGpPWpGaD
Ketamine—CYP3A4—Metabolism—AKT1—ovarian cancer	2.1e-06	1.89e-05	CbGpPWpGaD
